Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

24
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
24
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

18
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
18
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

14
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
14
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

134
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
134
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

57.2K
Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
57.2K
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

23
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
23

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Pulmonary Hypertension in Adults With a Systemic Right Ventricle (Biventricular Circulation).

JACC. Advances·2026
Same author

Lymphatic Abnormalities in Noonan Syndrome Extend Beyond Clinically Apparent Disease.

American journal of medical genetics. Part A·2026
Same author

Long-Term Outcomes of Antithrombotic Treatment in a Cohort of 864 Patients With Fontan Circulation.

Journal of the American Heart Association·2026
Same author

Mortality in patients with ventricular septal defect in Sweden: a national register study.

Open heart·2026
Same author

Trends in Congenital Heart Disease Hospitalizations: What Nearly 50 Years of Longitudinal Data and Segmented Regression Reveal.

Journal of the American Heart Association·2025
Same author

Standardized Mortality Ratio and Long-Term Stroke Incidence After PFO Closure: A Register Study.

JACC. Advances·2025

相关实验视频

Updated: Jul 26, 2025

Murine Fetal Echocardiography
08:04

Murine Fetal Echocardiography

Published on: February 15, 2013

17.4K

患有埃布斯坦异常的患者的死亡率

Filip Eckerström1, Mikael Dellborg2, Vibeke Elisabeth Hjortdal1

  • 1Department of Cardiothoracic Surgery, Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.

Journal of the American College of Cardiology
|June 21, 2023
PubMed
概括

与一般人群相比,埃布斯坦异常 (EA) 患者的死亡率仍然很高. 然而,近年来结果有所改善,特别是在现代时代诊断的较轻微病例中.

关键词:
埃布斯坦异常情况遗传性心脏病是一种先天性心脏病.死亡率 死亡率在全国范围内,在全国范围内.

更多相关视频

Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition
08:38

Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition

Published on: July 21, 2023

1.2K
A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse
08:19

A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse

Published on: December 16, 2022

1.9K

相关实验视频

Last Updated: Jul 26, 2025

Murine Fetal Echocardiography
08:04

Murine Fetal Echocardiography

Published on: February 15, 2013

17.4K
Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition
08:38

Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition

Published on: July 21, 2023

1.2K
A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse
08:19

A Pipeline to Characterize Structural Heart Defects in the Fetal Mouse

Published on: December 16, 2022

1.9K

科学领域:

  • 心脏病学 心脏病学
  • 儿童心脏病学 儿童心脏病学
  • 遗传性心脏病研究 遗传性心脏病研究

背景情况:

  • 埃布斯坦异常 (EA) 由于出生率低和转诊偏差存在诊断挑战,阻碍了自然历史研究.
  • 了解EA的长期结果和死亡率对于患者管理和治疗进步至关重要.

研究的目的:

  • 调查诊断出埃布斯坦异常的患者的死亡率和风险因素.
  • 将EA患者的死亡率与一般人群进行比较,并分析随着时间的推移的趋势.

主要方法:

  • 一项基于登记的研究,涉及丹麦和瑞典1970-2017年间被诊断患有EA的患者.
  • 根据出生年份和性别,将每个EA患者与10个一般人口对照进行匹配.
  • 使用卡普兰-梅尔和考克斯回归模型来计算累积死亡率和危险率 (HR).

主要成果:

  • 该研究包括530名EA患者和5300名对照人群,随访时间中位数为11年.
  • 在2000年以后诊断的患者中,累积死亡率与早期的患者相比显著降低 (P < 0.001).
  • 据推测患有严重EA的患者35年累积死亡率为18% (HR 36.2),轻度EA为11% (HR 6.0),两者都明显高于对照组.

结论:

  • 与一般人群相比,埃布斯坦异常患者的死亡率较高,无论相关的心脏形或诊断时间如何.
  • 在当代时代,EA的总死亡率有所改善,这表明了更好的管理策略.
  • 疾病严重程度是埃布斯坦异常患者长期生存的关键决定因素.